MONTREAL, 2 de junho de 2023 /PRNewswire/ — Knight Therapeutics Inc. (TSX: GUD) (“Knight”) uma empresa farmacêutica de especialidade líder no mercado pan-americana (ex-EUA), anunciou hoje que Samira Sakhia, presidente e diretora executiva, está programada para apresentar na Jefferies…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.